592 The growth of telehealth during SARS-CoV-2 time

Aims Improve the management of frail patients, particularly in times of pandemic, through an assistance based on a remote digitalized platform, which allows rapid interventions, able to reduce access to the emergency room, and decreased mortality from cardiovascular causes. Methods and results (i) Heart failure management—Enrollment in the digital platform. Use of devices: sphygmomanometer, scale, oximeter, single-track ECG. Daily analysis of the haemodynamic parameters on the platform. Communication by e-mail exchange and tele/videoconsultations, drug management, and therapeutic strategies. Possibility to perform echocardiogram at home. (ii) Remote monitoring management—Enrollment in the digital platform. Supply of transmitters for the management of thresholds, objectives, and alarms. Daily parametric check. (iii) Infarct network management—Integrated operating system for assistance between the in-hospital and out-of-hospital environment, in patients suffering from AMI. Execution, transmission, and reporting of the ecg-graphic trace on equipment provided with a remote transmission system. Allow to reduce the time of diagnosis and treatment. At our centers, over 1000 patients are followed on a digital platform, including those at risk of heart failure and device wearers. In addition, there is an annual trend of over 400 patients who are diagnosed electronically with AMI and relative percutaneous coronary treatment. The use of remote systems has allowed for some patients to early highlight threatening arrhythmias and/or device malfunctions, for others to prematurely intercept symptoms and signs of congestive heart failure. A clear improvement in prognosis and quality of life was therefore observed. Conclusions Cardiovascular diseases are the leading cause of death in Western countries. Therefore, the close follow-up and identification of haemodynamic and clinical parameters on digitized platforms, allows to: reduce access to the emergency room, guarantee the best therapeutic strategies, improve the quality of life, and decrease the mortality rate. In conclusion, we found a high approval rating as the patient reports feeling better, feeling constantly followed, and a clear improvement in compliance and adherence to the therapy.